Blog

  • A Black Eye From the Thanksgiving Touch-Football Game? When It Is Just a Bruise and When It Needs an Exam

    Thanksgiving afternoon, two uncles go up for the same pass in the backyard, and one comes inside holding a bag of frozen peas to his face. By evening the eyelids are puffy and purple. Most black eyes look worse than they are. But the eyelids and the bones around the eye are my specialty, and I want families to know which signs mean “watch it at home” and which mean “go now.”

    What a black eye is

    The American Academy of Ophthalmology (AAO) describes a black eye as bruising around the eye after an injury to the face or head. Blood and fluid collect in the loose skin around the eye, which is one of the first places to swell. Despite the name, the eye itself is usually not injured, and many black eyes heal on their own in a few days.

    What can hide behind the bruise

    The AAO notes that a black eye can be a sign of more serious injury:

    • Hyphema, bleeding inside the front of the eye, which can affect the cornea and vision
    • bleeding or damage in the back of the eye
    • increased pressure inside the eye
    • fractures of the thin bones around the eyeball
    • if both eyes are black after a head injury, a possible skull fracture

    Warning signs that need care now

    • double vision or vision loss
    • blood on the surface of the eye or inside it
    • trouble moving the eye
    • a severe or ongoing headache
    • fainting or loss of consciousness
    • blood or fluid from the ears or nose

    What the exam includes

    The doctor checks vision and eye movements, the pupil’s reaction to light, eye pressure, and the inside of the eye after dilation, and feels the bones around the eye. An X-ray or CT scan may be ordered if a fracture or something inside the eye is suspected.

    Home care for an ordinary black eye

    • On the first day, apply an ice pack for 15 to 20 minutes at a time, once every hour. Frozen vegetables or ice wrapped in cloth work too. Do not press on the eye.
    • Never put raw steak or other raw meat on it. The AAO notes this has no scientific basis and carries a high risk of infection.
    • Acetaminophen can help pain. Avoid NSAIDs such as ibuprofen if possible, to reduce the risk of more bleeding.
    • Skip sports and anything else that could hit the eye until it heals.

    Call your ophthalmologist if pain or swelling does not improve after a few days or if your vision changes.

    For more about the retina at the back of the eye, which can also be affected by a hard blow, this retina education blog is a good resource.

    Source: What Is a Black Eye? (American Academy of Ophthalmology, 6/24/2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.

  • A Red, Swollen Eyelid After a Holiday Cold: Preseptal Cellulitis, and the Warning Signs It Has Spread Behind the Eye

    Winter colds and sinus infections travel well, especially when families gather for the holidays. Every year, a few of those colds end with a phone call to my office: “My eyelid is red, hot and swollen, and it is getting bigger.” Most of the time, the cause is an infection of the eyelid tissue called preseptal cellulitis. It needs treatment, and it also needs one important question answered: has it spread behind the eye?

    A thin wall that matters

    EyeWiki, the American Academy of Ophthalmology’s clinical encyclopedia, explains that the orbital septum is a sheet of fibrous tissue that divides the tissues around the eye into two compartments. Infection in front of it, mainly in the eyelid, is preseptal cellulitis. Infection behind it, around the eye muscles and fat, is orbital cellulitis, which is more serious.

    How the infection gets there

    According to EyeWiki, there are three main routes:

    • Direct entry after an eyelid injury or an infected insect bite.
    • Spread from nearby structures, most commonly the sinuses, but also a stye or chalazion, an infected tear sac, skin infections, or shingles and cold sores near the eye.
    • Through the bloodstream from an upper respiratory or middle ear infection.

    Most cases are caused by bacteria, typically staphylococcus and streptococcus species. Because the veins draining the eyelids, orbit and sinuses lack valves, infection can move between these spaces, which is why doctors take eyelid swelling seriously.

    Signs that point to orbital cellulitis

    A swollen lid with otherwise normal eye findings fits preseptal cellulitis. Go to an emergency department or see an ophthalmologist immediately if you notice:

    • pain when moving the eye
    • double vision
    • an eye that looks pushed forward or bulging
    • reduced or blurry vision
    • fever, or a child who looks unwell

    Children are affected more often than adults, so parents should be especially watchful.

    How it is treated

    Preseptal cellulitis is usually treated with antibiotics and close follow-up, while orbital cellulitis often requires hospital care and intravenous antibiotics, sometimes with imaging and surgical drainage. Do not try to wait out a hot, swollen, tender eyelid. Do not squeeze a stye that has become red and swollen, and do not use leftover antibiotic drops; they are not the right treatment for an infection in the eyelid tissue.

    Prevention this season

    • Treat sinus infections and follow your doctor’s advice if symptoms drag on.
    • Use warm compresses for styes and chalazia, and keep hands away from the eyes.
    • Clean any scratch or bite near the eye gently, and watch it for spreading redness.

    For readers who want plain-language explanations of other eye conditions, this glaucoma education blog covers the optic nerve and eye pressure.

    A puffy eyelid is common. A puffy eyelid with pain on eye movement or changing vision is an emergency. Knowing the difference keeps a holiday cold from becoming something worse.

    Source: Preseptal Cellulitis (EyeWiki, American Academy of Ophthalmology). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.

  • A Drooping Upper Eyelid: What Ptosis Is in Children and Adults, and How It Is Treated

    Patients often come in about a drooping eyelid because of how it looks in photos. But ptosis is not only cosmetic. A lid that hangs low enough can block part of your vision, and in a young child it can affect how the eye develops.

    What ptosis is

    The American Academy of Ophthalmology (AAO) defines ptosis as a drooping of the upper eyelid. It can be slight, or severe enough to cover the pupil and block vision. Both children and adults can have it.

    Ptosis in children

    Children born with ptosis (congenital ptosis) usually have a problem with the levator, the muscle that lifts the eyelid. Signs include a droopy lid, uneven eyelid creases, and a child tipping the head back, lifting the chin or raising the eyebrows to see. The AAO warns that a lid that blocks vision can lead to amblyopia (“lazy eye”), and children with ptosis can also develop astigmatism or misaligned eyes.

    Treatment depends on the child’s age, eyelid height, muscle strength and eye movements. Surgery may be recommended to improve vision, and any amblyopia must be treated too, with patching, glasses or drops. All children with ptosis need regular eye exams.

    Ptosis in adults

    In adults, ptosis (called acquired or involutional) usually happens when the levator muscle stretches or separates from the eyelid with age or after an injury. It can also follow some eye surgeries. Rarely, nerve or muscle diseases or tumors are the cause, which is why a complete exam comes first, sometimes with blood tests or imaging.

    Treatment options for adults

    • Surgery is the usual treatment. It is typically outpatient, with local anesthesia. Mild cases may need only a small adjustment of the lifting muscle; more severe ones may need the muscle shortened and reattached.
    • Prescription drops. The AAO notes a daily drop, oxymetazoline, can lift the lid somewhat in some adults with acquired ptosis. It must be used every day to keep working and does not help ptosis from injury or nerve problems.

    Before eyelid surgery

    Tell your surgeon about every medicine and supplement you take, especially aspirin, blood thinners or any bleeding problem.

    When a droopy lid is urgent

    A lid that droops suddenly, especially with double vision, a headache, a large pupil or weakness elsewhere, needs emergency evaluation.

    Some patients notice a droopy lid around the time of cataract surgery; this cataract surgery education site explains what to expect from that operation.

    If a droopy eyelid is getting in the way of your vision or your child’s, an oculoplastic surgeon can tell you what is causing it and what can be done.

    Source: What Is Ptosis? (American Academy of Ophthalmology, 11/12/2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.

  • A Sore on the Eyelid That Will Not Heal: What to Know About Basal Cell Carcinoma, the Most Common Eyelid Cancer

    Patients often ignore a small bump or scab on the eyelid for months, assuming it is a stye or dry skin. Most eyelid bumps are harmless. But one that bleeds, crusts, will not heal or slowly changes the shape of the lid deserves a closer look, because it may be basal cell carcinoma.

    The most common eyelid cancer

    According to EyeWiki, the American Academy of Ophthalmology’s clinical encyclopedia, basal cell carcinoma (BCC) is the most common eyelid malignancy, accounting for over 90% of malignant eyelid tumors. It is linked to ultraviolet light damage to the skin, particularly UVB.

    Who is at risk

    EyeWiki notes that BCC tends to occur in lightly pigmented people at sites of sun exposure, although it can occur with any skin tone. Radiation exposure is among the other risk factors listed.

    Signs to watch for

    • A skin lesion that does not heal
    • Ulceration, bleeding or crusting
    • Loss of eyelashes in one spot
    • Tiny visible blood vessels on the bump
    • A change in the shape or position of the eyelid

    EyeWiki also notes some lesions cause no symptoms at all, which is why a doctor should examine anything that persists.

    Diagnosis and treatment

    BCC can be suspected on examination, but the diagnosis is confirmed with a biopsy. EyeWiki describes BCC as nearly always locally invasive, so treatment is recommended to prevent damage to nearby tissue. The standard approach is complete surgical removal with margin control, using frozen sections or Mohs surgery to make sure no cancer cells remain at the edges. A topical cream has been used in some cases but is not as effective as surgery. EyeWiki reports five-year cure rates of up to 98%.

    Prevention

    EyeWiki recommends minimizing sun exposure with sunblock, hats, sunglasses and protective clothing.

    Who treats it

    Eyelid cancer surgery and reconstruction are performed by oculoplastic surgeons and Mohs surgeons, and we refer patients when a lesion looks suspicious. If you have not had an eye exam in a while, our first visit guide explains what a comprehensive exam includes, including a look at the eyelids.

    The rule I give patients is easy to remember: an eyelid spot that has not healed in a few weeks should be examined.

    Source: Basal Cell Carcinoma (EyeWiki, American Academy of Ophthalmology, reviewed 9/22/2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.

  • A Pill Before Treatment for Eye Melanoma? Phase 2 Results for Darovasertib in Uveal Melanoma

    Uveal melanoma is a rare cancer that starts inside the eye. When it is found, the standard treatments come at a cost to vision: removing the eye (enucleation) or placing a radioactive plaque against it (plaque brachytherapy). A phase 2 trial is testing whether a pill taken first can shrink the tumor and make those treatments less damaging.

    The drug and the trial

    Darovasertib is an oral drug that blocks protein kinase C (PKC). About 95% of uveal melanomas carry mutations in genes called GNAQ or GNA11 that keep PKC switched on. In the OptimUM-09 trial, presented by Lauren Dalvin, MD, of Mayo Clinic at the 2026 American Academy of Ophthalmology meeting, patients took darovasertib twice daily before their planned treatment. As of the data cutoff, 95 patients had been treated.

    What was reported

    • Eye preservation. Among 42 evaluable patients who had been facing enucleation, 24 (57%) were able to keep the eye and receive radiation instead.
    • Tumor shrinkage. 84% of patients in the enucleation group and 82% in the plaque group had some shrinkage.
    • Lower radiation doses. In 70.3% of patients planned for plaque therapy, projected radiation to key structures such as the fovea, optic nerve or lens went down.
    • Side effects. Most were low grade, such as diarrhea, nausea, fatigue and vomiting, but 26.3% had a grade 3 or higher event, and low blood pressure was among the serious ones.

    What it means

    No treatment is currently approved to shrink uveal melanoma before definitive therapy. These are early, single-arm results, and a randomized phase 3 trial (OptimUM-10) is under way. This is care that happens in specialized ocular oncology centers.

    What you can do

    • Have a dilated eye exam on schedule. Some eye tumors are found on routine exams before any symptoms.
    • Report new flashes, floaters, a shadow in your vision or a change in a known freckle in the eye.
    • If you are diagnosed, ask your ocular oncologist whether you qualify for a clinical trial.

    Our office does not treat eye cancer. We refer patients to ocular oncology specialists. Parents who want to understand eye health for younger family members can visit a children’s eye health resource.

    I share this news because it gives patients and families real hope: the goal is no longer only saving a life, but saving the eye and its vision too.

    Source: Neoadjuvant darovasertib preserves eyes in primary uveal melanoma (Ophthalmology Times, 10/10/2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.

  • Cancer Immunotherapy and the Eye Socket: What a Review of 81 Patients Shows About Orbital Inflammation

    Immune checkpoint inhibitors have changed cancer care. These medicines release the brakes on the immune system so it can attack tumors such as melanoma. But an energized immune system can also inflame healthy tissue. A systematic review from the University of Adelaide, published in November 2026, gathered what is known about one rare side effect: inflammation in the orbit, the bony socket around the eye.

    What the researchers did

    The team searched five medical databases in September 2026 and found 57 published reports describing 81 patients who developed orbital inflammation during or after checkpoint inhibitor treatment.

    What they found

    • Median age was about 66, and 63% were men. Melanoma was the most common cancer (about 41%).
    • Symptoms started a median of 6 weeks after treatment began.
    • The most common signs were limited or painful eye movement and double vision (70%) and bulging eyes (30%). Both sides were affected in about 3 of 4 patients.
    • The eye-moving muscles were inflamed in 83%. The tear gland and the optic nerve were rarely involved.
    • About 17% looked like thyroid eye disease, even though most of those patients had normal thyroid tests.
    • Two-thirds had immune side effects elsewhere, most often muscle inflammation (37%) and heart muscle inflammation (24%).
    • Steroids were used in 93%, and about 40% needed additional immune-calming treatment. Symptoms fully or partly resolved in 88%; about 10% had a recurrence.

    The authors concluded that this side effect has a distinct pattern and that its recognition should prompt urgent, team-based evaluation, including checks for heart and muscle involvement.

    What this means for you

    • If you are on immunotherapy and develop double vision, painful eye movement, eyelid swelling or bulging eyes, contact your oncology team the same day and arrange an eye exam.
    • Mention any new muscle weakness, chest pain or shortness of breath at the same time. These can be related and serious.
    • Do not stop cancer treatment on your own. Your oncologist and eye specialists will decide together.

    For readable explanations of retinal and inflammatory eye conditions, see this retina education site.

    Our office refers orbital inflammation to oculoplastic and oncology specialists. Early recognition is what protects both the eye and the patient.

    Source: Immune checkpoint inhibitor-associated orbital inflammation: a systematic review (Graefe’s Archive for Clinical and Experimental Ophthalmology (PubMed), 11/06/2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.

  • Teprotumumab for Thyroid Eye Disease: What 36 Studies Show About Benefits, Blood Sugar and Hearing

    Thyroid eye disease (TED) is an autoimmune condition, most often linked to Graves disease, that inflames the tissues around the eyes. It can make the eyes bulge (proptosis), cause double vision, and change a person’s appearance. Teprotumumab (Tepezza) was the first FDA-approved biologic medicine for moderate-to-severe TED. A new systematic review in the American Journal of Ophthalmology looked at how it performs in trials and in everyday practice.

    What the review included

    Researchers at Peking University First Hospital searched four databases through August 2026. They included 36 studies: 6 randomized controlled trials (4 of teprotumumab and 2 of similar medicines) and 30 real-world studies of intravenous teprotumumab in adults.

    Benefits

    • Eye bulging: in randomized trials, patients on teprotumumab were about 4.6 times as likely as those on placebo to have a meaningful reduction. In real-world studies, 82% of patients responded.
    • Double vision: trials favored teprotumumab about 2 to 1, and 60% of real-world patients improved.

    Side effects to know about

    • High blood sugar: more frequent with teprotumumab in trials and seen in 17% of patients in real-world studies.
    • Hearing problems: also more frequent in trials, and reported in 18% of real-world patients.

    The authors conclude that teprotumumab improves bulging and double vision across study types, but that blood sugar and hearing effects in real-world use call for careful patient selection and monitoring.

    If you have thyroid eye disease

    • Ask whether your TED is active (inflamed) or stable; treatment choices differ.
    • If teprotumumab is considered, ask about blood sugar checks, especially if you have diabetes or prediabetes, and about a baseline hearing test.
    • Report ringing in the ears, muffled hearing, or excessive thirst during treatment.
    • Not smoking is one of the most important steps for TED.
    • Protect the eye surface with lubricating drops if your lids do not close fully.

    TED is managed by oculoplastic or orbital specialists together with endocrinologists; ask your eye doctor for a referral. For more reading, see malibulasik.com.

    Source: Teprotumumab for Thyroid Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Real-World Studies (American Journal of Ophthalmology (PubMed), 09/29/2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.

  • Can a Device Measure Your Blink for Dry Eye? A Review of 9 Technologies Found Promise and Gaps

    How often and how completely you blink affects the tear film. A scoping review published October 5, 2026, in Eye looked at devices and apps that record and analyze blinks to help evaluate dry eye and other ocular surface diseases.

    What the reviewers did

    They searched PubMed, Embase, and CENTRAL from January 1, 2000, through August 17, 2025, for technologies that capture blink metrics in ocular surface disease. Engineering-only papers and tools that were not used to evaluate the ocular surface were left out. Of 3,275 records, 42 studies met the criteria. The authors compared 9 technologies: desk-bound devices (Intelligent Vision Sensor, LipiView, and IDRA), wearables (Wink Glass and Blink-sensing Glasses), and smartphone or computer applications (HealthyRoad, DryEyeRhythm, “Dry eye or not?” and EyeScore). LipiView and IDRA were the most commonly studied.

    What they found

    • Blink rate and partial blink rate were the metrics analyzed most often, and dry eye disease was the condition studied most often.
    • In line with earlier research, studies linked a higher rate of partial blinks with a more compromised ocular surface.
    • Methods varied widely, and the accuracy and diagnostic value of the measured blink parameters were not sufficiently validated for diagnosing ocular surface disease.

    The reviewers concluded that these tools are promising but that more work is needed on validity, reliability, and real clinical usefulness. A blink app or camera is not a diagnosis. If your eyes feel dry, gritty, or tired, an eye exam can still look at the lids, glands, and tear film directly.

    Source: A scoping review of integrated blink analysis technologies for ocular surface diseases (Eye (PubMed), 05/10/2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.

  • Low Testosterone and Dry Eye: What Changed After Hormone Replacement in a 77-Man Study

    Androgens, including testosterone, play a role in the glands that help keep the eye surface stable. A study published November 6, 2026, in International Ophthalmology looked at the ocular surface in men with androgen deficiency and at what changed after testosterone replacement.

    Who was studied

    The study included 77 men; only the right eye of each participant was evaluated. Thirty-seven men had testicular hypofunction, defined as a total testosterone level below 231 ng/dL. Forty eugonadal controls had testosterone above 346 ng/dL. Examinations included symptom scores (AMS and OSDI), meibomian gland grading, corneal staining, tear breakup time (TBUT), Schirmer I and II tests, tear osmolarity, and anterior-segment OCT of the inferior tear meniscus. The androgen-deficiency group received intramuscular testosterone (Sustanon 250 mg) every two weeks, and measurements were repeated at weeks 6 and 18.

    What they found

    • At baseline, men with low testosterone had higher AMS and OSDI scores, worse meibomian gland grades, more corneal staining, and higher tear osmolarity, and they had lower Schirmer values, shorter TBUT, and a smaller tear meniscus.
    • After replacement therapy, testosterone levels rose, and AMS and OSDI scores, tear osmolarity, meibomian grades, and corneal staining improved. Schirmer tests and tear-meniscus measurements increased. TBUT also increased, but that change was not statistically significant.
    • Testosterone levels correlated negatively with AMS, OSDI, and tear osmolarity, and more weakly with meibomian grade and staining, and positively with TBUT, Schirmer II, and tear-meniscus measures.

    The authors concluded that androgen deficiency can affect the ocular surface, and that replacement was associated with favorable changes in several signs and symptoms in men who already needed treatment for androgen deficiency. This is not evidence that testosterone should be used as a dry-eye drug in men with normal hormone levels, and hormone therapy has its own risks that belong in a conversation with the prescribing physician. If you have known low testosterone and new dry-eye symptoms, mention both to your doctors.

    Source: The effects of androgen replacement therapy on tear osmolarity and ocular surface parameters in androgen deficiency (International Ophthalmology (PubMed), 06/11/2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.

  • Eye Pressure During Surgery: A Randomized Trial Compared Spinal and General Anesthesia

    Eye pressure, or intraocular pressure (IOP), can change while you are under anesthesia, even when the operation is not on the eye. A randomized trial published in September 2026 in Saudi Medical Journal compared spinal anesthesia with general anesthesia in adults having lumbar spine or lower-extremity orthopedic surgery.

    What the researchers did

    Sixty adults were randomly assigned to spinal anesthesia or general anesthesia. IOP, mean systemic arterial pressure, and heart rhythm were recorded at set times: baseline, before the spinal injection or induction, after the injection or induction, 5 minutes after the spinal procedure or intubation, 30 minutes into surgery, at the end of surgery, and 5 minutes after surgery or extubation.

    What they found

    • Baseline eye pressure was similar in both groups (about 14.3 mmHg with spinal anesthesia and 14.6 mmHg with general anesthesia).
    • The largest drop in IOP in both groups was right after the spinal injection or induction of general anesthesia. The drop at that point was more marked in the general anesthesia group.
    • After intubation, IOP was significantly higher with general anesthesia (19.82 mmHg) than with spinal anesthesia (12.86 mmHg).
    • At 30 minutes and at the end of surgery, IOP stayed lower in the spinal group than in the general anesthesia group.
    • Five minutes after surgery, IOP in both groups was slightly above baseline, but the difference from baseline was not statistically significant.
    • In the prone (face-down) position, IOP at mid-surgery and at the end of surgery was significantly higher than at the start in both groups, and the increase was larger with general anesthesia.

    The authors concluded that IOP may rise during both types of anesthesia, but the increase was greater with general anesthesia. This was not an eye-surgery trial, and it does not tell us which anesthetic is “safer” for every patient. If you have glaucoma or already-high eye pressure and are planning surgery, it is reasonable to mention that to your surgical and anesthesia team so they can take it into account.

    Source: Comparison of the Effects of Spinal Versus General Anesthesia on the Perioperative Intraocular Pressure (Saudi Medical Journal (PubMed), September 2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.